These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 20093349

  • 1. Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.
    Silva F, Specks U, Kalra S, Hogan MC, Leung N, Sethi S, Fervenza FC.
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):445-53. PubMed ID: 20093349
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of mycophenolate mofetil treatment for patients with microscopic polyangiitis: an observational study in Chinese patients.
    Chen Y, Gao E, Yang L, Liu X, Li K, Liu Z, Zeng C, Zhang H, Liu Z, Hu W.
    Rheumatol Int; 2016 Jul; 36(7):967-74. PubMed ID: 27169414
    [Abstract] [Full Text] [Related]

  • 3. Effects of mycophenolate mofetil combined with corticosteroids for induction therapy of microscopic polyangiitis.
    Han F, Liu G, Zhang X, Li X, He Q, He X, Li Q, Wang S, Wang H, Chen J.
    Am J Nephrol; 2011 Jul; 33(2):185-92. PubMed ID: 21311184
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [Abstract] [Full Text] [Related]

  • 5. Effects of cyclophosphamide on the prognosis of Japanese patients with renal vasculitis associated with anti-neutrophil cytoplasmic antibody-positive microscopic polyangiitis.
    Iwabuchi M, Nakaya I, Tsuchiya Y, Shibagaki Y, Yamaguchi T, Fukuhara S, Oe Y, Sakuma T, Sato T, Taguma Y, Soma J.
    Clin Exp Nephrol; 2016 Oct; 20(5):712-719. PubMed ID: 26590052
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.
    PLoS One; 2017 Oct; 12(10):e0185880. PubMed ID: 29016646
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement.
    Nowack R, Göbel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ.
    J Am Soc Nephrol; 1999 Sep; 10(9):1965-71. PubMed ID: 10477149
    [Abstract] [Full Text] [Related]

  • 8. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, Kumar V, Kohli HS, Sakhuja V, Jha V, Gupta KL.
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [Abstract] [Full Text] [Related]

  • 9. Use of mycophenolate in ANCA-associated renal vasculitis: 13 years of experience at a university hospital.
    Draibe J, Poveda R, Fulladosa X, Vidaller A, Zulberti C, Gomà M, Pujol R, Ripoll È, Torras J, Grinyó JM.
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i132-7. PubMed ID: 25805744
    [Abstract] [Full Text] [Related]

  • 10. Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis.
    Berti A, Alsawas M, Jawaid T, Prokop LJ, Lee JM, Jeong GH, Quintana LF, Moiseev S, Vaglio A, Tesar V, Geetha D, Shin JIL, Kronbichler A.
    Nephrol Dial Transplant; 2022 Oct 19; 37(11):2190-2200. PubMed ID: 34910216
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial.
    Tuin J, Stassen PM, Bogdan DI, Broekroelofs J, van Paassen P, Cohen Tervaert JW, Sanders JS, Stegeman CA.
    Clin J Am Soc Nephrol; 2019 Jul 05; 14(7):1021-1028. PubMed ID: 31253599
    [Abstract] [Full Text] [Related]

  • 13. Favourable renal survival in paediatric microscopic polyangiitis: efficacy of a novel treatment algorithm.
    Basu B, Mahapatra TK, Mondal N.
    Nephrol Dial Transplant; 2015 Apr 05; 30 Suppl 1():i113-8. PubMed ID: 25758433
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CM, St Clair EW, Ikle D, Tchao NK, Ding L, Brunetta P, Choi HK, Monach PA, Fervenza F, Stone JH, Specks U, RAVE-ITN Research Group.
    Ann Rheum Dis; 2016 Jun 05; 75(6):1166-9. PubMed ID: 26621483
    [Abstract] [Full Text] [Related]

  • 15. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE, Sanders JSF, Puéchal X, Guillevin LP, Hiemstra TF, Flossmann O, Rasmussen N, Westman K, Jayne DR, Stegeman CA.
    Rheumatology (Oxford); 2017 Nov 01; 56(11):1894-1901. PubMed ID: 28977502
    [Abstract] [Full Text] [Related]

  • 16. Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A propensity score-matched analysis of two nationwide prospective cohort studies.
    Watanabe H, Sada KE, Matsumoto Y, Harigai M, Amano K, Fujimoto S, Dobashi H, Yuzawa Y, Yamagata K, Muso E, Arimura Y, Makino H.
    Mod Rheumatol; 2021 Jan 01; 31(1):205-213. PubMed ID: 31859544
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of severe IgA nephropathy: mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone.
    Liu X, Dewei D, Sun S, Xu G, Liu H, He L, Zhang P.
    Int J Clin Pharmacol Ther; 2014 Feb 01; 52(2):95-102. PubMed ID: 24161158
    [Abstract] [Full Text] [Related]

  • 19. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
    Rheumatology (Oxford); 2014 Sep 01; 53(9):1570-7. PubMed ID: 24505125
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.